Xeomin is the latest wrinkle-reducing dermal filler on the market.
Xeomin, Botox and Dysport are all classified as botulinum toxins and work similarly by temporarily relaxing muscles that produce frown lines and wrinkles when they are injected in to the specific muscles. Because of the close relation of all toxins, they work uniquely in each person. Xeomin will join Botox Cosmetic® and Dysport by Medicis, as the third wrinkle-relaxer available to patients and physicians.
Xeomin differs from Botox and Dysport because it doesn’t need to be refrigerated. In addition, there are no additives to Xeomin – just botulinum toxin type A. This may lessen a patients’ anticipated response of developing antibodies, which means better results.
Although Xeomin is more often compared to Botox Cosmetic rather than Dysport, it takes about one week to notice full effect of the product. There has been some speculation that it can last up to six months with some patients, where Botox typically lasts 3 to 4 months.
All dermal fillers should be administered by registered nurses, doctors and/or plastic surgeons. Xeomin should not be injected in beauty salons, malls or at Xeomin parties in the home. This may make it more convenient for your doctor to store it.
Along with cosmetic use, Merz Aesthetics received FDA approval for XEOMIN® (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients in August 2011.
Many plastic surgeons and nurses are now injecting Xeomin, and patients love it. Contact a plastic surgeon in your area to learn more about Xeomin and other dermal filler products.
The information on this site is not a substitute for diagnosis or treatment from a licensed medical practitioner. If you are experiencing a serious medical condition call your local emergency services or your doctor.